TBVI and IAVI have updated the TB Vaccine Development Pathway. This online tool provides a structured development path and gating criteria for TB vaccine candidates and may be useful for vaccine development in general.
This online tool provides a structured development path and gating criteria for TB vaccine candidates, and may be useful for any vaccine development. In addition to TB specific considerations and target populations, the updated Pathway now includes vaccine technologies and community engagement, and expands on market, access and implementation.
For more information, please read the news item “Updated TB Development Pathway 2021 ”
